Company intelligence / Profile preview

Fileclo

Łódź, Łódzkie, Polandfileclo.com ↗
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

FiLeClo is a Polish biotechnology company focused on developing a multi-target small-molecule drug platform based on semisynthetic derivatives of salinomycin, a natural polyether ionophore. The company's proprietary platform aims to revolutionize cancer treatment by selectively targeting cancer stem cells and metastasis while overcoming drug resistance and avoiding the severe toxic side effects associated with traditional chemotherapy. FiLeClo's lead candidate, FLC-436, is a highly active and selective cytostatic drug candidate entering Phase 1 clinical trials for solid tumors. Beyond oncology, the company is leveraging its ionophore chemistry expertise to develop preclinical programs for obesity (FLC-XAO, a mitochondrial uncoupler), Gram-positive bacterial infections (FLC-XAB), viral infections (FLC-XAV), and protozoal infections (FLC-XAP).

Therapeutic areas
EndocrinologyOncologyInfectious Diseases
Modalities
Small molecule
Industry
Biotech
02

Partnerships

Agencja Badań MedycznychEXEQBiotech Innovation Institute

Beyond the preview

Go deeper on Fileclo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fileclo.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call